about
The complement system as a potential therapeutic target in rheumatic disease.A transient ischemic attack mimic.Immunological Rare Diseases.Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study.The role of complement components C1q, MBL and C1 inhibitor in pathogenesis of endometriosis.Refractory Abdominal Pain in a Patient with Chronic Lymphocytic Leukemia: Be Wary of Acquired Angioedema due to C1 Esterase Inhibitor Deficiency.
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Novelties in the Diagnosis and Treatment of Angioedema
@ast
Novelties in the Diagnosis and Treatment of Angioedema
@en
Novelties in the Diagnosis and Treatment of Angioedema
@nl
type
label
Novelties in the Diagnosis and Treatment of Angioedema
@ast
Novelties in the Diagnosis and Treatment of Angioedema
@en
Novelties in the Diagnosis and Treatment of Angioedema
@nl
prefLabel
Novelties in the Diagnosis and Treatment of Angioedema
@ast
Novelties in the Diagnosis and Treatment of Angioedema
@en
Novelties in the Diagnosis and Treatment of Angioedema
@nl
P356
P1476
Novelties in the Diagnosis and Treatment of Angioedema
@en
P2093
P304
212-21; quiz two pages after page 221
P356
10.18176/JIACI.0087
P407
P577
2016-01-01T00:00:00Z